$108.45 +2.91 (2.76%) Gilead Sciences Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM
Key Statistics
Last Trade: 108.45
Trade Time: Dec 19 04:00 PM Eastern Daylight Time
Change: +2.91 (2.76%)
Prev Close: 105.54
Open: 105.89
Bid: 108.44
Ask: 108.45

Competitors

Ticker Name Volume % Change
ARIA Ariad Pharmaceuticals Inc 11.38M +9.23%
AMGN Amgen Inc 7.42M +1.00%
NVAX Novavax Inc 5.87M +0.85%
CERS Cerus Corporation 5.76M +4.06%
HALO Halozyme Therapeutics Inc 5.50M +4.88%

GILD Stock Analysis

Partner Headlines

  1. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD | Dec. 19, 2014 | 19:05PM EST
  2. AbbVie Hep-C Drug Gets Nod

    IBD | Dec. 19, 2014 | 18:47PM EST
  3. United Therapeutics Lung Drug Keeps Going And Going

    IBD | Dec. 19, 2014 | 17:20PM EST
  4. Stocks Press Higher; Biotechs Gilead, Biogen Rise

    IBD | Dec. 19, 2014 | 15:08PM EST
  5. Stocks Off Highs But Stay Positive; Nike Drags Dow

    IBD | Dec. 19, 2014 | 13:27PM EST
  6. Is it Time to Sell Gilead Sciences?

    GuruFocus | Dec. 18, 2014 | 11:27AM EST